These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2445955)

  • 1. Regulation of isoproterenol-induced cyclic AMP accumulation in LRM55 glial cells by phosphodiesterase.
    Madelian V; Shain W
    J Pharmacol Exp Ther; 1987 Nov; 243(2):618-23. PubMed ID: 2445955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators.
    Derian CK; Santulli RJ; Rao PE; Solomon HF; Barrett JA
    J Immunol; 1995 Jan; 154(1):308-17. PubMed ID: 7995950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate.
    Cubeddu L; Barnes E; Weiner N
    J Pharmacol Exp Ther; 1975 Apr; 193(1):105-27. PubMed ID: 166157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes.
    Simmons MA; Hartzell HC
    Mol Pharmacol; 1988 Jun; 33(6):664-71. PubMed ID: 2454387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart.
    Bian JS; Zhang WM; Pei JM; Wong TM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1065-70. PubMed ID: 10688624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the phosphodiesterase regulated by muscarinic cholinergic receptors of 1321N1 human astrocytoma cells.
    Tanner LI; Harden TK; Wells JN; Martin MW
    Mol Pharmacol; 1986 May; 29(5):455-60. PubMed ID: 2422535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homologous and heterologous adenylate cyclase system desensitization in glial cells.
    Rampello L
    Funct Neurol; 1992; 7(2):97-102. PubMed ID: 1376710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma and lipopolysaccharide reduce cAMP responses in cultured glial cells: reversal by a type IV phosphodiesterase inhibitor.
    Patrizio M; Costa T; Levi G
    Glia; 1995 Jun; 14(2):94-100. PubMed ID: 7558245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities of S49 lymphoma cells by agents increasing cyclic AMP.
    Honeysett JM; Insel PA
    J Cyclic Nucleotide Res; 1981; 7(5):321-32. PubMed ID: 6284819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic stimulation of adenine nucleotide catabolism and purine release in human adipocytes.
    Kather H
    J Clin Invest; 1990 Jan; 85(1):106-14. PubMed ID: 1688563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phosphodiesterase inhibitors on Sertoli cell refractoriness: reversal of the impaired androgen aromatization.
    Conti M; Monaco L; Geremia R; Stefanini M
    Endocrinology; 1986 Mar; 118(3):901-8. PubMed ID: 2419118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
    Ransjö M; Fredholm BB; Lerner UH
    Bone Miner; 1988 Jan; 3(3):225-34. PubMed ID: 2462948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of bradykinin stimulation of renal medullary prostaglandin E2 synthesis by phosphodiesterase inhibitors.
    Rapp NS; Zenser TV; Mattammal MB; Davis BB
    J Pharmacol Exp Ther; 1981 Nov; 219(2):442-6. PubMed ID: 6169824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis fibroblasts respond normally to isoproterenol.
    Kurz JB; Perkins JP
    Pediatr Res; 1981 Oct; 15(10):1328-33. PubMed ID: 6170925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of renal ecto-phosphodiesterase.
    Jackson EK; Ren J; Zacharia LC; Mi Z
    J Pharmacol Exp Ther; 2007 May; 321(2):810-5. PubMed ID: 17308037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of glycogenolysis by beta adrenergic agonists in skeletal muscle of mice with the phosphorylase kinase deficiency mutation (I strain).
    Gross SR; Mayer SE; Longshore MA
    J Pharmacol Exp Ther; 1976 Sep; 198(3):526-38. PubMed ID: 978457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterases in the rat renal vasculature.
    Jackson EK; Mi Z; Carcillo JA; Gillespie DG; Dubey RK
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):798-801. PubMed ID: 9436820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
    Meeker RB; Harden TK
    Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of human and rabbit vaginal smooth muscle cell cultures: effects of vasoactive agents on intracellular levels of cyclic nucleotides.
    Traish A; Moreland RB; Huang YH; Kim NN; Berman J; Goldstein I
    Mol Cell Biol Res Commun; 1999 Aug; 2(2):131-7. PubMed ID: 10542137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the adenylyl cyclase signaling system in various types of cultured endothelial cells.
    Manolopoulos VG; Samet MM; Lelkes PI
    J Cell Biochem; 1995 Apr; 57(4):590-8. PubMed ID: 7542252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.